SMTL ID : 5j9l.1

Crystal structure of CPT1691 bound to TAK1-TAB1

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.75 Å

Oligo State

monomer

Ligands

1 x 6HF: N-(4-((2-((4-(4-methylpiperazin-1-yl)phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)phenyl)acrylamide(Non-covalent)

6HF.1: 19 residues within 4Å: Chain A: V.16, G.17, V.24, A.35, V.64, M.78, E.79, Y.80, A.81, E.82, G.84, S.85, Y.87, N.88, P.134, N.135, L.137, C.148, F.150 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:V.16, A:Y.80, A:Y.87, A:P.134, A:L.137, A:F.150 Hydrogen bonds: A:E.79, A:A.81, A:A.81, A:S.85, A:P.134 Water bridges: A:S.85

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tan, L. et al., Structure-guided development of covalent TAK1 inhibitors. Bioorg. Med. Chem. (2017)

Release Date

2017-02-15

Peptides

Mitogen-activated protein kinase kinase kinase 7,TGF-beta-activated kinase 1 and MAP3K7-binding protein 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase kinase kinase 7,TGF-beta-activated kinase 1 and MAP3K7-binding protein 1

Related Entries With Identical Sequence